High prevalence of arthropathy in HTLV-I carriers on a Japanese island

Annals of the Rheumatic Diseases

Volumn 55, Issue 3, 1996, Pages 193-195

  Motokawa, Satoru ^a   Hasunuma, Tomoko ^b   Tajima, Kazuo ^c   Krieg, Arthur M ^d   Ito, Shin Ichiro ^e   Iwasaki, Katsuro ^f   Nishioka, Kusuki ^b  

^a Nagasaki Chuo National Hospital   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d UNIVERSITY OF IOWA   (United States)

^e Izuhara Hospital   (Japan)

^f NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTHRITIS; ARTICLE; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0029967584     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.55.3.193     Document Type: Article

References (15)

1. Nishioka K, Maruyama I, Maruyama Y, Kitajima I, Nakajima Y, Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1989; 1: 441.
2. Iwakura Y, Tosu M, Yoshida E, et al. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 1991; 253: 1026-8.
3. Kitajima I, Yamamoto K, Sato K, et al. Detection of human T cell lymphotropic virus type I proviral DNA and its gene expression in synovial cell in chronic inflammatory arthropathy. J Clin Invest 1991; 88: 1315-22.
4. Nakajima T, Aono H, Hasunuma T, et al. Overgrowth of human synovial cells driven by the HTLV-I tax gene. J Clin Invest 1991; 88: 1315-22.
5. Hasunuma T, Nakajima T, Aono H, et al. Establishment and characterization of synovial cell clones with integrated human T-cell leukemia virus type-I. Clin Immunol Immunopathol 1994; 72: 90-7.
6. Sato K, Maruyama I, Maruyama Y, et al. Arthritis in patients infected with human T lymphotropic virus type-I. Arthritis Rheum 1991; 34: 714-21.
7. Arnett F C, Edworthy S M, Bloch D A, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
8. Steinbrocker O, Traeger C H, Batterman R C. Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 659-62.
9. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; i: 1031-2.
10. Gessain A, Barin F, Vernant J C, Gout O, Maurs L, Calender A. Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet 1985; ii: 407-10.
11. Eguchi K, Matsuoka N, Ida H, et al. Primary Sjögren's syndrome with antibodies to HTLV-I: clinical and laboratory features. Ann Rheum Dis 1992; 51: 769-76.
12. Green J E, Hinrichs S H, Vogel J, Jay G. Exocrinopathy resembling Sjögren's syndrome in HTLV-I tax transgenic mice. Nature 1989; 341: 72-4.
13. Mochizuki M, Watanabe T, Yamaguchi K. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 1992; 83: 236-9.
14. Vernant J C, Buisson G, Magdeleine J, et al. T-lymphocyte alveolitis, tropical spastic paraparesis, and Sjögren's syndrome. Lancet 1988; i: 177.
15. Terada K, Katamine S, Eguchi K, et al. Prevalence of serum and salivary antibodies to HTLV-I in Sjögren's syndrome. Lancet 1994; 344: 1116-9.